AEterna Zentaris Inc. (AEZS)

[alexander77]

AEZS:$12/share target reaffirmed+institutional buying
stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued on Sunday.

Shares of Aeterna Zentaris (NASDAQ:AEZS) traded up 2.42% during midday trading on Friday, reaching $3.38. 107,781 shares of the company traded hands. Aeterna Zentaris has a 1-year low of $2.60 and a 1-year high of $25.00. The company’s market capitalization is $33.59 million. The company has a 50 day moving average price of $3.44 and a 200 day moving average price of $3.52.

An institutional investor recently raised its position in Aeterna Zentaris stock. Renaissance Technologies LLC boosted its stake in Aeterna Zentaris Inc. (NASDAQ:AEZS) by 5.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 516,833 shares of the biopharmaceutical company’s stock after buying an additional 29,000 shares during the period. Renaissance Technologies LLC owned about 8.17% of Aeterna Zentaris worth $1,716,000 as of its most recent filing with the SEC.

AEZS has been the subject of several other research reports. Maxim Group reaffirmed a “buy” rating and issued a $11.00 price target on shares of Aeterna Zentaris in a research report on Tuesday, May 10th. Canaccord Genuity reaffirmed a “buy” rating and issued a $9.00 price target (down previously from $13.00) on shares of Aeterna Zentaris in a research report on Monday, April 4th.

http://www.americanbankingnews.com/2016/07/11/aeterna-zentaris-aezs-buy-rating-reaffirmed-at-hc-wainwright/

http://www.smarteranalyst.com/2016/07/11/h-c-wainwright-pounds-table-aeterna-zentaris-inc-usa/